You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 4月27日港股收盤

根據uSMART輿情監測數據,27日港股交易時段,市場關注指數最高的5只股票是贛鋒鋰業、山東新華製藥股份、中國鋁業、萬洲國際、復星醫藥。

4月27日—港股關注排行TOP5

輿情變化榜單

贛鋒鋰業

個股K線圖

關注度第一爲贛鋒鋰業,該股今日收盤上漲12.50%,報於92.25港元。近5個交易日累計下跌3.55%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

贛鋒鋰業首季淨利潤大增640%至35.25億元人民幣

小摩:維持贛鋒鋰業“增持”評級 目標價180港元

山東新華製藥股份

個股K線圖

關注度第二爲山東新華製藥股份,該股今日收盤上漲50.23%,報於6.55港元。近5個交易日累計上漲41.77%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

新華製藥公告和真實生物簽署合作協議,山東新華製藥暴漲60%

山東新華製藥股份高開14.91% 與真實生物就阿茲夫定等產品簽署戰略合作協議

中國鋁業

個股K線圖

關注度第三爲中國鋁業,該股今日收盤上漲7.04%,報於3.65港元。近5個交易日累計下跌17.42%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

瑞信:中鋁季績符預期 評級「跑贏大市」看7元

中國鋁業AH股齊上揚 首季淨利潤同比增長60.52%

萬洲國際

個股K線圖

關注度第四爲萬洲國際,該股今日收盤下跌1.65%,報於5.38港元。近5個交易日累計下跌1.10%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

小摩:予萬洲國際“增持”評級 目標價下調至8.4港元

摩通下調萬洲目標價至8.4元 評級「增持」

復星醫藥

個股K線圖

關注度第五爲復星醫藥,該股今日收盤下跌5.93%,報於32.50港元。近5個交易日累計下跌1.96%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:

Q1淨利同比下降45.41% 復星醫藥A股低開8%

復星醫藥一季度淨利大幅下滑45%,公司股價大跌7%

此外,監測期內有3只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

4月27日—港股輿情轉折預警

輿情變化榜單

泰格醫藥

個股K線圖

泰格醫藥輿情扭轉指數達97,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。

其中較被市場關注的消息有:

野村下調泰格醫藥目標價至115.13元 評級「買入」

泰格醫藥績後跌超5% 野村下調其今明兩年的盈利預測

中國鋁業

個股K線圖

中國鋁業輿情扭轉指數達97,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

瑞信:中鋁季績符預期 評級「跑贏大市」看7元

中國鋁業AH股齊上揚 首季淨利潤同比增長60.52%

復星醫藥

個股K線圖

復星醫藥輿情扭轉指數達97,目前輿情方向爲利空,表明公司出現了被投資者視作較大利空的消息。

其中較被市場關注的消息有:

Q1淨利同比下降45.41% 復星醫藥A股低開8%

復星醫藥一季度淨利大幅下滑45%,公司股價大跌7%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account